Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Severe COVID-19 may lower hemoglobin levels

Publish date:: April 15, 2020

Key clinical point: The hemoglobin value was significantly lower in severe COVID-19 patients, compared with those with milder forms.

Major finding: A weighted mean difference in hemoglobin content of −7.1 g/L (95% CI, −8.3 g/L to −5.9 g/L) was found in comparing severe to milder cases of COVID-19.

Study details: Meta-analysis of four studies of 1,210 COVID-19 patients with assessable hemoglobin values.

Disclosures: The authors declared that they had no conflicts of interest.

Citation:

Lippi G et al. Hematol Transfus Cell Ther. 2020 Apr 11; doi:10.1016/j.htct.2020.03.001.

This Week's Must Reads

COVID-19 vaccine found effective but doctors watching for reactions, adverse events,

Study links sleep meds and dementia risk in older adults,

Childhood Hodgkin survivors have neurocognitive impairment,

Obesity, hypoxia predict severity in children with COVID-19,

Long-term safety and efficacy of teriflunomide for relapsing MS,

Must Reads in COVID-19 Updates

COVID-19 vaccine found effective but doctors watching for reactions, adverse events,

Obesity, hypoxia predict severity in children with COVID-19,

Whales, seals, and dolphins: Will SARS-CoV-2–contaminated wastewater prove a killer?,

COVID-19 in pregnancy raises risk of preterm birth and severe disease,

New case suggestive of in utero SARS-CoV-2 transmission,